Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.

acute kidney diseases and disorders acute kidney injury chronic kidney disease kidney disease kidney failure kidney function kidney measures nomenclature patient-centeredness precision medicine

Journal

Kidney international
ISSN: 1523-1755
Titre abrégé: Kidney Int
Pays: United States
ID NLM: 0323470

Informations de publication

Date de publication:
06 2020
Historique:
received: 31 12 2019
revised: 10 02 2020
accepted: 14 02 2020
pubmed: 16 5 2020
medline: 22 6 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

The worldwide burden of kidney disease is rising, but public awareness remains limited, underscoring the need for more effective communication by stakeholders in the kidney health community. Despite this need for clarity, the nomenclature for describing kidney function and disease lacks uniformity. In June 2019, Kidney Disease: Improving Global Outcomes (KDIGO) convened a Consensus Conference with the goal of standardizing and refining the nomenclature used in the English language to describe kidney function and disease, and of developing a glossary that could be used in scientific publications. Guiding principles of the conference were that the revised nomenclature should be patient-centered, precise, and consistent with nomenclature used in the KDIGO guidelines. Conference attendees reached general consensus on the following recommendations: (i) to use "kidney" rather than "renal" or "nephro-" when referring to kidney disease and kidney function; (ii) to use "kidney failure" with appropriate descriptions of presence or absence of symptoms, signs, and treatment, rather than "end-stage kidney disease"; (iii) to use the KDIGO definition and classification of acute kidney diseases and disorders (AKD) and acute kidney injury (AKI), rather than alternative descriptions, to define and classify severity of AKD and AKI; (iv) to use the KDIGO definition and classification of chronic kidney disease (CKD) rather than alternative descriptions to define and classify severity of CKD; and (v) to use specific kidney measures, such as albuminuria or decreased glomerular filtration rate (GFR), rather than "abnormal" or "reduced" kidney function to describe alterations in kidney structure and function. A proposed 5-part glossary contains specific items for which there was general agreement. Conference attendees acknowledged limitations of the recommendations and glossary, but they considered standardization of scientific nomenclature to be essential for improving communication.

Identifiants

pubmed: 32409237
pii: S0085-2538(20)30233-7
doi: 10.1016/j.kint.2020.02.010
pii:
doi:

Types de publication

Practice Guideline Research Support, Non-U.S. Gov't Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1117-1129

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Auteurs

Andrew S Levey (AS)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA. Electronic address: alevey@tuftsmedicalcenter.org.

Kai-Uwe Eckardt (KU)

Department of Nephrology and Medical Intensive Care, Charité-Universitätsmedizin Berlin, Berlin, Germany. Electronic address: kai-uwe.eckardt@charite.de.

Nijsje M Dorman (NM)

Managing Editor, American Journal of Kidney Diseases.

Stacy L Christiansen (SL)

Managing Editor, Journal of the American Medical Association.

Ewout J Hoorn (EJ)

Department of Internal Medicine, Division of Nephrology and Transplantation, Erasmus Medical Center, University Medical Center Rotterdam, Rotterdam, The Netherlands.

Julie R Ingelfinger (JR)

Harvard Medical School, Boston, Massachusetts, USA; Department of Pediatrics, Massachusetts General Hospital, Boston, Massachusetts, USA.

Lesley A Inker (LA)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.

Adeera Levin (A)

Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.

Rajnish Mehrotra (R)

Kidney Research Institute, University of Washington School of Medicine, Seattle, Washington, USA; Harborview Medical Center Division of Nephrology, Department of Medicine, University of Washington School of Medicine, Seattle, Washington, USA.

Paul M Palevsky (PM)

Renal Electrolyte Division, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Mark A Perazella (MA)

Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut, USA; Veterans Affairs Medical Center, West Haven, Connecticut, USA.

Allison Tong (A)

Sydney School of Public Health, University of Sydney, Sydney, New South Wales, Australia; Centre for Kidney Research, The Children's Hospital at Westmead, Westmead, New South Wales, Australia.

Susan J Allison (SJ)

Chief Editor, Nature Reviews Nephrology.

Detlef Bockenhauer (D)

Renal Unit, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK; Department of Renal Medicine, University College London, London, UK.

Josephine P Briggs (JP)

Editor-in-Chief, Journal of the American Society of Nephrology.

Jonathan S Bromberg (JS)

Department of Surgery, Division of Transplantation, University of Maryland School of Medicine, Baltimore, Maryland, USA; Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.

Andrew Davenport (A)

Royal Free London NHS Foundation Trust, London, UK.

Harold I Feldman (HI)

Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Center for Clinical Epidemiology and Biostatistics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Denis Fouque (D)

Department of Nephrology, Centre Hospitalier Lyon Sud, Lyon, France.

Ron T Gansevoort (RT)

Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.

John S Gill (JS)

Division of Nephrology, University of British Columbia, Vancouver, British Columbia, Canada.

Eddie L Greene (EL)

Division of Nephrology and Hypertension, Mayo Clinic, Rochester, Minnesota, USA.

Brenda R Hemmelgarn (BR)

Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Department of Community Health Sciences, University of Calgary, Calgary, Alberta, Canada.

Matthias Kretzler (M)

Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA; Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, Michigan, USA.

Mark Lambie (M)

Institute for Science and Technology in Medicine, Keele University, Crewe, UK.

Pascale H Lane (PH)

Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.

Joseph Laycock (J)

Managing Editor, Pediatric Nephrology.

Shari E Leventhal (SE)

Executive Editor, American Society of Nephrology, Washington, DC, USA.

Michael Mittelman (M)

American Living Organ Donor Fund, Philadelphia, Pennsylvania, USA.

Patricia Morrissey (P)

Executive Managing Editor, Kidney International.

Marlies Ostermann (M)

Department of Critical Care, King's College London, Guy's & St Thomas' Hospital, London, UK.

Lesley Rees (L)

Department of Pediatric Nephrology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.

Pierre Ronco (P)

Sorbonne Université, Paris, France; Institut National de la Santé et de la Recherche Médicale (Inserm), Unité Mixte de Recherche UMR S1155, Paris, France; Hôpital de jour - Néphrologie, Assistance Publique-Hôpitaux de Paris, Hôpital Tenon, Paris, France.

Franz Schaefer (F)

Division of Pediatric Nephrology, Center for Pediatrics and Adolescent Medicine, Heidelberg University, Heidelberg, Germany.

Jennifer St Clair Russell (J)

National Kidney Foundation, New York, New York, USA.

Caroline Vinck (C)

Managing Editor, Nephrology Dialysis Transplantation.

Stephen B Walsh (SB)

Center for Nephrology, University College London, London, UK.

Daniel E Weiner (DE)

Division of Nephrology, Tufts Medical Center, Boston, Massachusetts, USA.

Michael Cheung (M)

Kidney Disease: Improving Global Outcomes (KDIGO), Brussels, Belgium.

Michel Jadoul (M)

Cliniques Universitaires Saint Luc, Université Catholique de Louvain, Brussels, Belgium.

Wolfgang C Winkelmayer (WC)

Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH